Drawing for TRANSSET

USPTO serial 79344595

TRANSSET

Reviewed by CopyMark Law Group

Reg. 7014861Status 700Registered
Filing date
Status date
Registration date
Apr 4, 2023
Examiner
BETTS, MARCYA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TRANSSET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cheryl L. Burbach

Cheryl L. Burbach Erise IP, P.A.7015 College Blvd.Suite 700Overland Park, KS 66211

Goods and services

ClassDescriptionStatusFirst use
010Catheters; intravenous catheter sets comprised of catheters, tubing, tube clamps, luer tapers, valves, syringes, needles; medical and surgical catheters; medical catheters for flushing purposes; catheters for surgical purposes; luer tapers for medical use; inoculating apparatus, namely, needles and syringes for medical purposes, and infusion pumps; medical tubing for administering contrast fluids, administering drugs, drainage, transfusion; surgical and medical apparatuses and instruments, namely, medical fluid injectors, medical contrast media injectors, medical contrast delivery systems; surgical and medical apparatuses and instruments for handling fluids, namely, medical fluid injectors; surgical and medical apparatuses and instruments intended for the injection of liquids, namely, medical fluid injectors; surgical and medical apparatuses and instruments intended for measuring blood reflux; fluid injectors for medical purposes; transfusion sets; infusion sets; infusion instruments, whether or not with clamps or valves or disconnect functions, namely, fluid warmer and medical infusion pumps; transfusion instruments, whether or not with clamps or valves or disconnect functions, namely, blood transfusion apparatusACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 23, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 23, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 23, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 23, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 7, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Aug 14, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jul 25, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB
Jul 25, 2023FIMPFINAL DISPOSITION PROCESSED
Jul 4, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 4, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 4, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 24, 2023GPNXNOTIFICATION PROCESSED BY IB
Jan 17, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 17, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 4, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 4, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 28, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 12, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 9, 2022XAECEXAMINER'S AMENDMENT ENTERED
Dec 9, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 9, 2022GNEAEXAMINERS AMENDMENT E-MAILED
Dec 9, 2022CNEAEXAMINERS AMENDMENT -WRITTEN
Nov 28, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 28, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 28, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 18, 2022RFNPREFUSAL PROCESSED BY IB
Sep 25, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 24, 2022RFRRREFUSAL PROCESSED BY MPU
Aug 5, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 4, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2022DOCKASSIGNED TO EXAMINER
Jul 15, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Jul 11, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 8, 2022SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance